Werewolf Therapeutics, Inc. (HOWL)
0.9744
-0.01
(-1.43%)
USD |
NASDAQ |
Sep 11, 11:36
Werewolf Therapeutics Total Liabilities (Quarterly) : 7.863M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.863M |
| March 31, 2026 | 45.82M |
| December 31, 2025 | 44.59M |
| September 30, 2025 | 50.01M |
| June 30, 2025 | 51.10M |
| March 31, 2025 | 49.93M |
| December 31, 2024 | 56.11M |
| September 30, 2024 | 50.66M |
| June 30, 2024 | 49.68M |
| March 31, 2024 | 60.01M |
| December 31, 2023 | 63.46M |
| September 30, 2023 | 63.94M |
| Date | Value |
|---|---|
| June 30, 2023 | 66.64M |
| March 31, 2023 | 74.00M |
| December 31, 2022 | 37.91M |
| September 30, 2022 | 41.48M |
| June 30, 2022 | 45.49M |
| March 31, 2022 | 25.31M |
| December 31, 2021 | 26.46M |
| September 30, 2021 | 9.072M |
| June 30, 2021 | 8.862M |
| March 31, 2021 | 7.092M |
| December 31, 2020 | 7.179M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.873M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.16M |
| Shareholders Equity (Quarterly) | 16.29M |
| Current Ratio | 2.911 |
| Net Debt Paydown Yield | 42.32% |